Independent report

Report of the Commission on Human Medicine’s Expert Working Group on benefit-risk and risk minimisation measures of the yellow fever vaccine

An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the benefit-risk and risk minimisation measures of the yellow fever vaccine.

Documents

Details

An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the benefit-risk and risk minimisation measures of the yellow fever vaccine.

Updates to this page

Published 21 November 2019

Sign up for emails or print this page